Outcomes in Patients with Hematologic Malignancies Infected with Sars-Cov-2: The Northwestern University Experience

Background: The rapid global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains the international public health concern of the decade. Early clinical data suggest that patients (pts) with hematologic malignancies are vulnerable to severe forms of SARS-CoV-2 and have high...

Descripción completa

Detalles Bibliográficos
Autores principales: Galvez, Carlos, Nizamuddin, Imran, Tuchman, Emily, Doukas, Peter, Reddy, Neha, Altman, Jessica K., Winter, Jane N., Gordon, Leo I., Barth, Dylan, Hodgins, Nicole, Pro, Barbara, Ma, Shuo, Dinner, Shira, Frankfurt, Olga, Mehta, Jayesh, Singhal, Seema, Adekola, Kehinde, Moreira, Jonathan, Tanna, Sajal D, Wehbe, Firas, Karmali, Reem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
905.Outcomes Research-Malignant Conditions (Lymphoid Disease)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330301/
http://dx.doi.org/10.1182/blood-2020-139495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330301/
http://dx.doi.org/10.1182/blood-2020-139495

Ejemplares similares